PLGA8K-PEG2K-CRTLTVRK(5-FITC)C
Poly(L-lactide-co-glycolide)-Polyethylene glycol-CRTLTVRK(5-FITC)C
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-5421 | 300mg | 600.00 | + Add to cart |
|
| R-C-5421 | 500mg | 1050.00 | + Add to cart |
|
|
||||
Product description
The PLGA component provides sustained release and biodegradability, PEGylation improves stability and bioavailability, the CRTLTVRK sequence enables specific targeting, and the FITC label allows for fluorescence imaging capabilities. This compound can be utilized for targeted drug delivery, imaging, and potentially personalized therapy, depending on the specific target and therapeutic payload.
| Appearance | N/A |
|---|---|
| PEG Molecular weight | 2000 |
| purity | >95% |
| PDI by GPC | <1.5 |
| Storage | -20℃ protected from light and moisture |
| Transportation | 4-25℃temperature for up to 3 weeks |
| Stability | 1year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds----PLGA8K-PEG2K-CRTLTVRK(5-FITC)C
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


